JP2007533683A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533683A5
JP2007533683A5 JP2007508805A JP2007508805A JP2007533683A5 JP 2007533683 A5 JP2007533683 A5 JP 2007533683A5 JP 2007508805 A JP2007508805 A JP 2007508805A JP 2007508805 A JP2007508805 A JP 2007508805A JP 2007533683 A5 JP2007533683 A5 JP 2007533683A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
treatment
group
composition according
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007508805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533683A (ja
Filing date
Publication date
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed filed Critical
Priority claimed from PCT/EP2005/004073 external-priority patent/WO2005102349A1/de
Publication of JP2007533683A publication Critical patent/JP2007533683A/ja
Publication of JP2007533683A5 publication Critical patent/JP2007533683A5/ja
Pending legal-status Critical Current

Links

JP2007508805A 2004-04-22 2005-04-18 呼吸器系疾患治療用のベンゾオキサジン含有医薬組成物 Pending JP2007533683A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07
PCT/EP2005/004073 WO2005102349A1 (de) 2004-04-22 2005-04-18 Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen

Publications (2)

Publication Number Publication Date
JP2007533683A JP2007533683A (ja) 2007-11-22
JP2007533683A5 true JP2007533683A5 (https=) 2008-10-23

Family

ID=34966478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007508805A Pending JP2007533683A (ja) 2004-04-22 2005-04-18 呼吸器系疾患治療用のベンゾオキサジン含有医薬組成物

Country Status (33)

Country Link
EP (2) EP1781298B1 (https=)
JP (1) JP2007533683A (https=)
KR (2) KR101287460B1 (https=)
AR (1) AR049262A1 (https=)
AT (1) ATE539754T1 (https=)
AU (1) AU2005235419B2 (https=)
BE (1) BE2015C065I2 (https=)
BR (1) BRPI0510080B8 (https=)
CA (1) CA2559699C (https=)
CY (3) CY1113890T1 (https=)
DK (2) DK2422786T3 (https=)
EA (1) EA013157B1 (https=)
EC (1) ECSP066947A (https=)
ES (2) ES2523518T3 (https=)
FI (1) FIC20170005I1 (https=)
FR (1) FR16C0029I2 (https=)
HU (1) HUS1500058I1 (https=)
IL (2) IL177685A (https=)
LT (1) LTC1781298I2 (https=)
LU (1) LU93066I2 (https=)
MY (1) MY148945A (https=)
NL (1) NL300779I2 (https=)
NO (2) NO337714B1 (https=)
NZ (1) NZ550797A (https=)
PE (1) PE20060462A1 (https=)
PL (2) PL1781298T4 (https=)
PT (2) PT2422786E (https=)
SG (1) SG152237A1 (https=)
SI (2) SI1781298T1 (https=)
TW (2) TWI374739B (https=)
UY (1) UY28861A1 (https=)
WO (1) WO2005102349A1 (https=)
ZA (1) ZA200606624B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
US20070088030A1 (en) 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
ATE529399T1 (de) * 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
EP1986644A1 (de) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
CA2660186A1 (en) * 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US20100099651A1 (en) * 2006-10-26 2010-04-22 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
US8497369B2 (en) 2008-02-07 2013-07-30 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production
EP2313397B1 (de) 2008-08-08 2016-04-20 Boehringer Ingelheim International GmbH Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
WO2014056840A1 (en) 2012-10-09 2014-04-17 Boehringer Ingelheim International Gmbh Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
SK15382002A3 (sk) * 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
WO2002030928A1 (de) 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
ME00412B (me) 2001-06-22 2011-10-10 Boehringer Ingelheim Pharma Kristalni antiholinergik , postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Similar Documents

Publication Publication Date Title
JP2007533683A5 (https=)
CA2427282C (en) Mixtures or organic compounds for the treatment of airway diseases
US20120263655A1 (en) Combination of medicaments for the treatment of respiratory diseases
AU2002217082A1 (en) Mixtures or organic compounds for the treatment of airway diseases
ES2380370T3 (es) Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
TW200803840A (en) Organic compounds
JP2007500676A5 (https=)
CA2534120A1 (en) Medicaments for inhalation comprising anticholinergics and a betamimetic
CA2481268A1 (en) Medicaments comprising steroids and a novel anticholinergic
JP2009537585A (ja) 呼吸器疾患の治療のための新規医薬組成物
CA2534128A1 (en) Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
JP2009500310A5 (https=)
CA2650813A1 (en) New long-acting drug combinations for the treatment of respiratory diseases
JP2009526817A5 (https=)
CA2533792A1 (en) Medicaments for inhalation comprising steroids and fluorene carboxylic acid esters